Dorman Products, Inc.

DORM

CIK 0000868780 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$538M
↑+0.8% +$4Mvs FY2024 (Q4)
Operating Income
$31M
↓-64.0% -$56Mvs FY2024 (Q4)
Net Income
$12M
↓-78.8% -$43Mvs FY2024 (Q4)
Gross Profit
$229M
↑+3.3% +$7Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
56/100
  • Profitability
    36ROIC 12.2% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.09 (above 1.5 = solid)
  • Leverage
    85D/E 0.30 (under 0.5 = conservative)
  • Efficiency
    51Asset Turnover 0.87x (1.0+ = capital-efficient)
  • Growth
    19Revenue YoY +0.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    43Op Margin 5.8% · trend -0.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project DORM's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 170.9%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$82.06
Total enterprise IV
$2.52B
Diluted shares
0.03B
Terminal PV
$1.96B (78% of total)
Year-5 FCF
$231M
YearProjected FCFDiscounted PV
+1$95M$86M
+2$118M$98M
+3$148M$111M
+4$185M$126M
+5$231M$143M
Terminal$3.16B$1.96B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$38M
investment in PP&E
Stock-based comp (TTM)
$20M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$2.49B
everything owned
Stockholders' equity
$1.48B
shareholder claim
Net debt
$391M
LT debt minus cash

Recent performance · 64 quarters

Revenue↑+0.8% +$4M
$538M
Net Income↓-78.8% -$43M
$12M
Free Cash Flow↓-47.0% -$30M
$33M
Operating Margin↓-10.4pts
5.8%

Drill down